Maze Therapeutics MAZE Institutional Ownership

NASDAQ MAZE

$27.18 +0.16 (+0.59%)

At close: Sep 30, 2026 · 4:00 PM EDT

Institutions by Trading Activity

163 Institutions

Increased 106 65.0%

Unchanged 19 11.7%

Reduced 38 23.3%

Ownership Statistics

13F · as of 30 Jun, 2026

Institutional Ownership

99.66%

▲+3.78 pp QoQ

Shares Held by Institutions

58.80Mn

of 59.00Mn outstanding

▲+36.31% QoQ

Shares Outstanding

59.00Mn

200.50K held outside 13F filers

Institutional Investors

163

filed 13F for Jun 2026

▼-1 vs prior quarter

Net Shares Added (QoQ)

+15.66Mn

accumulated since last quarter

Value of Holdings

$1.60Bn

reported market value

Shares Owned by Institutions

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Institutions

Accumulated Distributed

Latest quarter —

Net over range —

Accumulating quarters —

Ownership Summary

Quarter ending 30 Jun, 2026

Maze Therapeutics, Inc. (NASDAQ:MAZE) is held by 163 institutional investors per 13F filings through June 2026.

They owned 99.7% of outstanding stock in June 2026, up from 95.9% the prior quarter.
They increased total shares held in Maze Therapeutics by 36.31% from last quarter, and the number of investors in MAZE increased 120.27% annually.
Activity in MAZE broke down as 106 buyers, 38 sellers, and 19 unchanged among 163 total holders.
Institutional investors collectively held 58.8Mn shares in Maze Therapeutics as of June 2026, up by 15.66Mn shares quarter on quarter, and up 19.99Mn shares year over year.
Frazier Life Sciences Management, L.P. is the top holder of Maze Therapeutics as of June 30, 2026, with 5.03Mn shares representing 8.53% of outstanding stock.
The largest buyers of Maze Therapeutics for the quarter ending June 2026 were Jupiter Topco LLC (3.41Mn), T. Rowe Price Investment Management, Inc. (2.6Mn), BRAIDWELL LP (1.14Mn), BlackRock, Inc. (932.42K), Jpmorgan Chase & Co (905.56K).
The largest sales of MAZE for the quarter ending June 2026 came from ADAGE CAPITAL PARTNERS GP, L.L.C. (930.0K), BALYASNY ASSET MANAGEMENT L.P. (440.96K), BOOTHBAY FUND MANAGEMENT, LLC (95.62K), Ensign Peak Advisors, Inc (84.15K), Morgan Stanley (69.66K).
Per Business Quant data, the top 10 holders of Maze Therapeutics for the quarter ending June 2026 are Frazier Life Sciences Management, L.P. (5.03Mn), TRV GP IV, LLC (4.47Mn), ARCH Venture Management, LLC (4.12Mn), Deep Track Capital, LP (3.73Mn), BlackRock, Inc. (3.5Mn), Jupiter Topco LLC (3.41Mn), T. Rowe Price Investment Management, Inc. (2.6Mn), Logos Global Management LP (1.93Mn), VANGUARD CAPITAL MANAGEMENT LLC (1.78Mn), a16z Capital Management, L.L.C. (1.7Mn).

Form 13F Holdings

163 Institutional Holders

Report period 30 Jun, 2026

Total shares held 58.80Mn

Of outstanding 99.66%

#	Institution	CIK	Shares Held	% of Outstanding	Change (QoQ)	Change (%)	Value (USD)
1	Frazier Life Sciences Management, L.P.	0001892134	5,032,915	8.53%	▲465,641	+10.20%	$150.18Mn
2	TRV GP IV, LLC	0001688325	4,473,958	7.58%	0	0.00%	$133.50Mn
3	ARCH Venture Management, LLC	0001274403	4,120,053	6.98%	0	0.00%	$122.98Mn
4	Deep Track Capital, LP	0001856083	3,732,569	6.33%	▲255,007	+7.33%	$111.38Mn
5	BlackRock, Inc.	0002012383	3,502,841	5.94%	▲932,416	+36.27%	$104.52Mn
6	Jupiter Topco LLC	0002146052	3,408,045	5.78%	▲3,408,045	0.00%	$101.76Mn
7	T. Rowe Price Investment Management, Inc.	0001897612	2,603,682	4.41%	▲2,603,682	0.00%	$77.69K
8	Logos Global Management LP	0001792126	1,935,000	3.28%	▲700,000	+56.68%	$57.74Mn
9	VANGUARD CAPITAL MANAGEMENT LLC	0002100119	1,778,222	3.01%	▲342,566	+23.86%	$53.06Mn
10	a16z Capital Management, L.L.C.	0001540358	1,702,225	2.89%	0	0.00%	$50.79Mn
11	Venrock Adviser, LLC	0001615982	1,602,034	2.72%	0	0.00%	$47.80Mn
12	Alphabet Inc.	0001652044	1,388,583	2.35%	0	0.00%	$41.44Mn
13	BRAIDWELL LP	0001920938	1,140,040	1.93%	▲1,140,040	0.00%	$34.02Mn
14	FARALLON CAPITAL MANAGEMENT, L.L.C.	0000909661	1,107,814	1.88%	▲734,814	+197.00%	$33.06Mn
15	FMR LLC	0000315066	1,056,959	1.79%	▲192,745	+22.30%	$31.54Mn
16	General Catalyst Group Management, LLC	0001637946	1,035,910	1.76%	0	0.00%	$30.91Mn
17	State Street Corp	0000093751	997,533	1.69%	▲360,811	+56.67%	$29.77Mn
18	Jpmorgan Chase & Co	0000019617	964,011	1.63%	▲905,565	+1,549.40%	$28.00Mn
19	DRIEHAUS CAPITAL MANAGEMENT LLC	0000938206	954,886	1.62%	▲318,724	+50.10%	$28.49Mn
20	TRV GP V, LLC	0001990717	950,800	1.61%	0	0.00%	$28.37Mn

Showing 1 to 20 of 163 holders